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Michael S. M. Brouwer1, Arie Kant1, Hilde Smith2, Daniela Ceccarelli1 & Dik Mevius1,4
The blaSHV-12 β-lactamase gene is one of the most prevalent genes conferring resistance to extended-
spectrum β-lactams in Enterobacteriaceae disseminating within and between reservoirs, mostly via 
plasmid-mediated horizontal gene transfer. Yet, studies regarding the biology of plasmids encoding 
blaSHV-12 are very limited. In this study, we revealed the emergence of IncX3 plasmids alongside IncI1α/γ 
in blaSHV-12 in animal-related Escherichia coli isolates. Four representative blaSHV-12-encoding IncX3 
plasmids were selected for genome sequencing and further genetic and functional characterization. 
We report here the first complete sequences of IncX3 plasmids of animal origin and show that IncX3 
plasmids exhibit remarkable synteny in their backbone, while the major differences lie in their blaSHV-12- 
flanking region. Our findings indicate that plasmids of this subgroup are conjugative and highly 
stable, while they exert no fitness cost on their bacterial host. These favourable features might 
have contributed to the emergence of IncX3 amongst SHV-12-producing E. coli in the Netherlands, 
highlighting the epidemic potential of these plasmids.
The emerging IncX plasmid family consists of narrow host-range, self-transferable, iteron-containing plasmids 
with class A theta replication and sizes ranging approximately between 30 and 100 kb1–3. IncX plasmids have 
a highly syntenic backbone; yet based on phylogenetic analysis they can be assigned to six distinct subgroups, 
namely IncX1 to IncX62,4,5. Although it has been demonstrated that IncX plasmids occurred only infrequently 
among commensal and pathogenic E. coli isolates6, plasmids of this family encoding various resistance genes were 
recently described in Enterobacteriaceae originating from diverse sources and geographical areas2,4,7–11. Among 
this plasmid family, the IncX3 subgroup mediates the spread of genes encoding resistance for clinically relevant 
first-line (fluoroquinolones and extended-spectrum cephalosporins) and last-resort (carbapenems) antibiot-
ics. IncX3 plasmids have been reported to encode qnrB79, qnrS12,9,12–15, blaCTX-M-311, blaSHV-129,16–19, blaKPC-220,21, 
blaKPC-322, blaNDM-118,19,23, blaNDM-424, blaNDM-525-28, blaNDM-715,26,29-33, blaNDM-1316, blaNDM-1734 and blaOXA-18112–14,35,36. 
Overall, these reports highlight the importance of this plasmid subgroup for the dissemination of antibiotic resist-
ance genes within Enterobacteriaceae.
The blaSHV-12 gene ranks amongst the most predominant extended-spectrum β-lactamases within 
Enterobacteriaceae of diverse origins37. Plasmid-mediated horizontal gene transfer constitutes a key mechanism 
by which this gene disseminates among bacterial populations, therefore monitoring the spread of plasmids is 
essential to track the transmission of the blaSHV-12 gene between different reservoirs37. Several plasmid replicon 
types have been associated with the worldwide dissemination of blaSHV-12, including A/C, colE, F, HI2, I1α/γ, K, 
L/M, N, P, R, as well as the recently emerging X337. The few available data on the prevalence of blaSHV-12-encoding 
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plasmids in the Netherlands, report IncHI2 plasmids in human Salmonella enterica isolates, IncN and IncF plas-
mids in human Escherichia coli37,38, as well as IncK plasmids in E. coli from poultry37.
To understand blaSHV-12 diffusion in the Netherlands, also in light of the emerging role of IncX3 plasmids 
worldwide, we investigated a collection of previously uncharacterized SHV-12-encoding E. coli isolates. We 
report here the plasmid epidemiology of SHV-12-producing E. coli from different reservoirs in The Netherlands, 
the first fully assembled and annotated sequence of three blaSHV-12 encoding-IncX3 plasmids of animal origin, and 
the genetic and functional characteristics of IncX3 plasmids from both human and animal origin.
Results
Plasmid epidemiology of blaSHV-12 and emergence of IncX3. Among the 129 blaSHV-12 encoding E. 
coli isolates included in this study (Table 1), 49.6% (n = 64) was isolated from food-producing animals, 41.1% 
(n = 53) from retail meat and 9.3% (n = 12) from humans. Plasmid typing revealed that blaSHV-12 was encoded 
by nine different plasmid families: I1α/γ (n = 86; 66.7%), X3 (n = 21; 16.3%), X1 (n = 6; 4.7%), F (n = 5; 3.9%), 
B/O (n = 4; 3.1%), K (n = 4; 3.1%), N (n = 1; 0.8%), colE (n = 1; 0.8%) and multi-replicon F-X1 (n = 1; 0.8%). 
A gradual decrease from 90.0% to 55.6% of IncI1α/γ in parallel with a significant increase from 0.0% to 24.1% 
(p = 0.041) of IncX3 was documented between 2011 and 2014 among food-producing animals and retail meat 
(Fig. 1). As a result, IncX3 plasmids were among the predominant rep-types encoding blaSHV-12 in the Netherlands 
from 2012 onwards (Fig. 1).
To further study these emerging IncX3 plasmids, four of them (pEC-NRS18, pEC-393, pEC-125 and pEC-
243) randomly selected from human-related E. coli ST69 and from diverse E. coli STs of animal origin (ST117, 
ST315 and ST410) were fully sequenced and functionally characterized in this study (Table 2).
IncX3 plasmid backbone is highly syntenic and conserved. Comparison between whole sequences 
of the four IncX3 plasmids from this study and twenty IncX3 plasmids available in GenBank revealed a highly 
conserved plasmid backbone and their organization into a number of distinct clades (Fig. 2). Plasmids of ani-
mal origin pEC-125 and pEC-243 were closely clustered together (MUMi distance 0.018) and grouped with 
the human-derived plasmid pEC-NRS18 that showed distance from 0.085 (pEC-125) to 0.093 (pEC-243). The 
animal-derived plasmid pEC-393 (turkey meat) clustered with a Klebsiella pneumoniae-encoded pIncX-SHV 
from human source in Italy (MUMi distance 0.002). IncX3 plasmids recovered in the Netherlands clustered 
closely with pOXA181 (China) and pKS22 (Switzerland) encoding blaOXA-181 and qnrS1, respectively, with MUMi 
distances varying from 0.140 (pOXA181 with pEC-125) to 0.179 (pKS22with pEC-393).
The four plasmids sequenced, assembled and fully annotated in this study had sizes varying from 43,506 
(pEC-393) to 48,250 (pEC-NRS18) bp with an average GC content of 46.5% (Table 2). Similar to other IncX3 plas-
mids, they carried three putative origins of replication (oriV-α, oriV-β and oriV-γ), two origins of transfer (oriT-α 
and oriT-β), and approximately 6 iteron sequences. Nucleotide sequence analysis revealed 65 to 74 predicted open 
reading frames (Fig. 3). Comparative genomic of all four plasmids (Fig. 3) revealed high synteny among them, 
encoding genes for replication (pir: replication initiation protein and bis: replication accessory protein), partition-
ing (parAB), entry exclusion (eex), maintenance (topB and hns), transcriptional activation (actX), and conjugative 
transfer [pilX1-11 (type IV secretion system) and taxA-C]. In addition, a mosaic variable region containing resist-
ance genes as well as intact and/or defective insertion sequences (i.e. IS21, ISKpn19, Tn3, and IS26) was identified 
in all four plasmids upstream of the partitioning gene parA (Fig. 3).
The variable region of pEC-NRS18 contained blaTEM-1 embedded in a Tn3 transposon, as well as genes blaSHV-12 
and qnrS1 associated with the upstream presence of IS26 in the opposite and same orientation, respectively. 
Similarly, pEC-125 and pEC-243 contained both blaSHV-12 and qnrS1 genes, whereas pEC-393 encoded only 
blaSHV-12 associated to IS26. The genetic environment surrounding blaSHV-12 was characterized by two flanking 
copies of IS26 distributed in opposite orientation to form a composite IS26-IS26 transposon (3,633 bp); this struc-
ture was conserved in three of the four IncX3 plasmids (pEC-NRS18, pEC-125 and pEC-243; Fig. 3). BLAST 
analysis revealed that this composite transposon is 100% identical to previously described transposons located 
on plasmids of K. pneumoniae (IncFIB; GenBank accession no. CP019048.1) and Aeromonas veronii (IncA/C2; 
GenBank accession no. CP014775.1), as well as into the genome of Pseudomonas aeruginosa (GenBank accession 
no. GU592828.1). The flanking region of blaSHV-12 on pEC-393 showed a partial 2,484-bp overlap with corre-
sponding regions of pEC-NRS18, pEC-125 and pEC-243 (Fig. 3) and encoded genes deoR, ygbJ and truncated 
ygbK also present on several K. pneumoniae chromosomes (GenBank accession no. CP000647, CP002910 and 
CP008831). This 4,783-bp region exhibits 100% identity to a fragment of a blaSHV-harboring IncR plasmid of K. 
pneumoniae (GenBank accession no. KF954150.1).
IncX3 plasmid transfer is temperature-dependent. Conjugation frequencies of the four IncX3 plas-
mids was determined and results are shown in Fig. 4. Transfer rates differed between solid matings at different 
temperatures. Geometric mean frequencies ranged below the detection limit (≤1 × 10−9, pEC-393) to 3.73 × 10−5 
(pEC-NRS18) at 25 °C, from 6.36 × 10−6 (pEC-393) to 7.16 × 10−5 (pEC-243) at 30 °C, and from 1.33 × 10−6 
(pEC-393) to 1.46 × 10−4 (pEC-NRS18) at 37 °C. The analysis showed a significant difference between conjuga-
tion frequencies at different temperatures (p = 0.027), mainly due to lower frequencies at 25 °C compared with 
frequencies at 30 °C. The difference in conjugation frequencies between different plasmids was nearly significant 
(p = 0.054). Comparisons of single plasmids at 30 °C and 37 °C indicated differences between the plasmids at 
37 °C, with lower conjugation frequencies for animal-derived plasmids (pEC-125, pEC-243 and pEC-393), and 
higher frequencies for the human-derived plasmid pEC-NRS18. Overall, plasmid of animal origins seem to trans-
fer better at 30 C, conversely to the human-derived plasmid (Fig. 4).
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Isolate
Date of 
isolation Origin ESBL gene(s)*
Inc/rep-type of blaSHV-
12-encoding plasmid
1954014 2009 Livestock (pig) blaSHV-12 IncF
35474 2009 Livestock (poultry) blaSHV-12 IncF
36289 2009 Livestock (poultry) blaSHV-12 IncI1α/γ
36278 2009 Livestock (poultry) blaSHV-12 IncI1α/γ
513768 2009 Livestock (poultry) blaSHV-12 IncI1α/γ
37318 2009 Livestock (poultry) blaSHV-12 IncI1α/γ
35078 2009 Livestock (poultry) blaSHV-12 IncI1α/γ
37881 2009 Livestock (poultry) blaCTX-M-1 (IncI1α/γ), blaCMY-2 (IncK), blaSHV-12
IncX3
35659 2009 Livestock (poultry) blaCTX-M-1 (IncN), blaSHV-12 IncI1α/γ
36498 2010 Livestock (poultry) blaSHV-12 IncI1α/γ
36700 2010 Livestock (poultry) blaSHV-12 IncI1α/γ
36809 2010 Livestock (poultry) blaSHV-12 IncI1α/γ
66191451 2010 Livestock (poultry) blaSHV-12 IncI1α/γ
35568 2010 Livestock (poultry) blaSHV-12 IncI1α/γ
636942 2010 Livestock (poultry) blaSHV-12 IncI1α/γ
1026302 2010 Livestock (poultry) blaSHV-12 IncI1α/γ
1025601 2010 Livestock (poultry) blaSHV-12 IncI1α/γ
55833907 2011 Livestock (pig) blaSHV-12 IncF
55927588 2011 Livestock (pig) blaSHV-12 IncI1α/γ
55927758 2011 Livestock (pig) blaSHV-12 IncI1α/γ
37156 2011 Livestock (poultry) blaSHV-12 IncI1α/γ
36239 2011 Livestock (poultry) blaSHV-12 IncI1α/γ
55727422 2011 Livestock (cattle) blaSHV-12 IncI1α/γ
884 2011 Livestock (poultry) blaSHV-12 IncI1α/γ
1105 2011 Livestock (poultry) blaSHV-12 IncI1α/γ
1109 2011 Livestock (poultry) blaSHV-12 IncI1α/γ
984 2011 Livestock (poultry) blaSHV-12 IncI1α/γ
65268442 2012 Livestock (pig) blaSHV-12 IncI1α/γ
36788 2012 Livestock (poultry) blaSHV-12 IncI1α/γ
29062012-02 2012 Livestock (poultry) blaSHV-12 IncI1α/γ
55580200139 2012 Livestock (poultry) blaSHV-12, blaTEM-52c IncK
65094754 2012 Livestock (cattle) blaSHV-12 IncI1α/γ
36458 2013 Livestock (poultry) blaSHV-12 IncI1α/γ
35658 2013 Livestock (poultry) blaSHV-12 IncI1α/γ
1399001 2013 Livestock (poultry) blaSHV-12 IncX3
859 2014 Livestock (poultry) blaSHV-12 IncX3
219 2014 Livestock (poultry) blaSHV-12 IncX3
1041 2014 Livestock (poultry) blaSHV-12 IncI1α/γ
900 2014 Livestock (poultry) blaSHV-12 IncI1α/γ
570 2014 Livestock (poultry) blaSHV-12 IncX3
500 2014 Livestock (poultry) blaSHV-12 IncB/O
374 2014 Livestock (poultry) blaSHV-12 IncI1α/γ
287 2014 Livestock (poultry) blaSHV-12 IncX3
73¥ 2014 Livestock (poultry) blaSHV-12 IncX3
1424 2014 Livestock (poultry) blaSHV-12 IncX3
71 2014 Livestock (poultry) blaSHV-12 IncI1α/γ
828 2014 Livestock (poultry) blaSHV-12 IncX1
1003 2014 Livestock (poultry) blaSHV-12 IncI1α/γ
11 2014 Livestock (poultry) blaSHV-12 IncI1α/γ
240 2014 Livestock (poultry) blaSHV-12 IncF-X1
386¥ 2014 Livestock (poultry) blaSHV-12 IncX3
990 2014 Livestock (poultry) blaSHV-12 IncI1α/γ
1341 2014 Livestock (poultry) blaSHV-12 IncI1α/γ
1420 2014 Livestock (poultry) blaSHV-12 IncX3
118 2014 Livestock (poultry) blaSHV-12 IncI1α/γ
Continued
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Isolate
Date of 
isolation Origin ESBL gene(s)*
Inc/rep-type of blaSHV-
12-encoding plasmid
139 2014 Livestock (poultry) blaSHV-12 IncX3
864 2014 Livestock (poultry) blaSHV-12 IncX1
1206 2014 Livestock (poultry) blaSHV-12 IncI1α/γ
876 2014 Livestock (poultry) blaSHV-12 IncI1α/γ
20 2014 Livestock (poultry) blaSHV-12 IncX1
229 2014 Livestock (poultry) blaSHV-12 IncX3
1096 2014 Livestock (poultry) blaSHV-12 IncF
1433 2014 Livestock (pig) blaSHV-12 IncX3
1116 2014 Livestock (cattle) blaSHV-12 IncI1α/γ
69438407 2012 Meat (poultry) blaCTX-M-1 (IncI1α/γ), blaSHV-12
IncX3
69606962 2012 Meat (poultry) blaSHV-12 IncX3
76495084 2012 Meat (beef) blaSHV-12 IncI1α/γ
76495084 02 2012 Meat (beef) blaSHV-12 IncI1α/γ
69843204 2012 Meat (poultry) blaSHV-12 IncI1α/γ
69210023 2012 Meat (poultry) blaSHV-12 IncK
69843409 2012 Meat (poultry) blaSHV-12 IncI1α/γ
69438105 2012 Meat (poultry) blaSHV-12 IncX3
69585604 2012 Meat (poultry) blaSHV-12 IncI1α/γ
69064655 2012 Meat (poultry) blaSHV-12 IncI1α/γ
69770576 2012 Meat (poultry) blaSHV-12, blaTEM-52c IncI1α/γ
69477895 2012 Meat (poultry) blaSHV-12, blaTEM-52c IncI1α/γ
69927807 2013 Meat (poultry) blaCMY-2 (IncK), blaSHV-12 IncB/O
698975250004 2013 Meat (poultry) blaSHV-12 colE
699561810004 2013 Meat (poultry) blaSHV-12 IncI1α/γ
699819760004 2013 Meat (poultry) blaSHV-12 IncI1α/γ
69986056 2013 Meat (poultry) blaSHV-12 IncI1α/γ
693784120004 2013 Meat (poultry) blaSHV-12 IncI1α/γ
693785440004 2013 Meat (poultry) blaSHV-12 IncI1α/γ
693562060004 2013 Meat (poultry) blaSHV-12 IncI1α/γ
699898610004 2013 Meat (poultry) blaSHV-12 IncI1α/γ
699229530004 2013 Meat (poultry) blaSHV-12 IncI1α/γ
698980410004 2013 Meat (poultry) blaSHV-12 IncI1α/γ
69960219 2013 Meat (poultry) blaSHV-12 IncI1α/γ
69960316 2013 Meat (poultry) blaSHV-12 IncI1α/γ
69960316 2013 Meat (poultry) blaSHV-12 IncI1α/γ
69345093 2013 Meat (pork) blaSHV-12 IncI1α/γ
69799639 2013 Meat (beef) blaSHV-12 IncI1α/γ
699799710004 2013 Meat (beef) blaSHV-12 IncI1α/γ
694658380004 2013 Meat (poultry) blaSHV-12, blaSHV-2A, blaTEM-
52c (IncI1α/γ)
IncI1α/γ
699813050004 2013 Meat (poultry) blaSHV-12, blaTEM-52c (IncI1α/γ) IncI1α/γ
699900020004 2013 Meat (poultry) blaSHV-12 IncK
693503480004 2013 Meat (poultry) blaSHV-12 IncX1
699953490004 2013 Meat (poultry) blaSHV-12 IncX1
699081950004 2013 Meat (poultry) blaSHV-12 IncX1
699952170004 2013 Meat (poultry) blaSHV-12 IncX3
69960189¥ 2013 Meat (poultry) blaSHV-12 IncX3
79158224 2014 Meat (beef) blaSHV-12 IncF
M14P0112 2014 Meat (poultry) blaSHV-12 IncI1α/γ
79197637 2014 Meat (poultry) blaSHV-12 IncI1α/γ
79059943 2014 Meat (poultry) blaSHV-12 IncI1α/γ
79230383 2014 Meat (poultry) blaSHV-12 IncB/O
79696536 2014 Meat (poultry) blaSHV-12 IncI1α/γ
79194778 2014 Meat (pork) blaSHV-12 IncI1α/γ
79195006 2014 Meat (poultry) blaSHV-12 IncI1α/γ
Continued
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IncX3 plasmids exert no fitness cost to the bacterial host and are highly stable. The cost of IncX3 
plasmid presence on the host cell fitness was assessed in the absence and in the presence of cefotaxime by com-
paring the exponential growth rate of E. coli DH10b with and without plasmid (Fig. 5). The exponential growth 
rates of E. coli DH10b harbouring each of the IncX3 plasmids singularly varied from 0.91 (95% CI 0.84–0.99; 
DH10b::pEC-125) to 1.22 (95% CI 1.13–1.32; DH10b::pEC-NRS18) in the absence of antibiotic selective pressure, 
and from 1.48 (95% CI 1.14–1.83; DH10b::pEC-NRS18) to 1.94 (95% CI 1.77–2.12; DH10b::pEC-243) in the 
presence of cefotaxime. In the absence of cefotaxime, DH10b::pEC-125 showed significantly lower (p = 0.04) and 
DH10b::pEC-NRS18 significantly higher (p < 0.001) exponential growth rates compared to E. coli DH10b control 
strain. Pairwise comparison of the relative growth rates for E. coli DH10b harbouring each of the IncX3 plasmids 
in the absence and presence of cefotaxime indicated significantly higher rates in the presence of selective pressure 
(p < 0.001) except for DH10b::pEC-NRS18.
Isolate
Date of 
isolation Origin ESBL gene(s)*
Inc/rep-type of blaSHV-
12-encoding plasmid
79156655 2014 Meat (poultry) blaSHV-12 IncI1α/γ
79207004 2014 Meat (poultry) blaSHV-12 IncI1α/γ
79626295 2014 Meat (poultry) blaSHV-12 IncB/O
79207101 2014 Meat (poultry) blaSHV-12 IncI1α/γ
79352292 2014 Meat (poultry) blaSHV-12 IncK
79771872 2014 Meat (poultry) blaSHV-12 IncX3
79445126 2014 Meat (poultry) blaSHV-12 IncI1α/γ
79042587 2014 Meat (poultry) blaSHV-12 IncX3
1190900169¥ 2009 Human (urine) blaSHV-12 IncX3
1190900881 2009 Human (urine) blaSHV-12 IncI1α/γ
1190900890 2009 Human (urine) blaSHV-12 IncI1α/γ
306 2014 Human (faeces) blaSHV-12 IncI1α/γ
1.1 2014 Human (faeces) blaSHV-12 IncI1α/γ
1.58 2014 Human (faeces) blaSHV-12 IncI1α/γ
2.12 2014 Human (faeces) blaSHV-12 IncI1α/γ
2.25 2014 Human (faeces) blaSHV-12 IncI1α/γ
2.48 2014 Human (faeces) blaSHV-12 IncI1α/γ
2.49 2014 Human (faeces) blaSHV-12 IncI1α/γ
2.52 2014 Human (faeces) blaSHV-12 IncI1α/γ
1.71 2014 Human (faeces) blaSHV-12 IncN
Table 1. Characteristics of the 129 non-duplicate blaSHV-encoding E. coli isolates included in the study. *When 
known the inc/rep-type of the plasmid encoding ESBL genes (excluding the blaSHV-12) is given in parenthesis. ¥In 
bold the 4 plasmids sequenced and functionally characterized.
Figure 1. Prevalence of plasmid encoding blaSHV-12 in E. coli isolated between 2009 and 2014 in the 
Netherlands. Isolates were recovered from food-producing animals, retail meat and humans during national 
antimicrobial resistance monitoring programmes or national projects. Plasmids belonging to N, colE and F-X1 
replicon types were recovered with prevalence of 0.85% and therefore were omitted from the figure.
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E. coli DH10b transformed strains were also propagated without positive antibiotic selective pres-
sure as a measure of plasmid stability. After approximately 180 generations of growth, the percentage of 
plasmid-harbouring cells in each population (for all four plasmids singularly) was determined. All plasmids were 
found to be stably maintained in the E. coli population, ranging from 99.9% (95% CI 99.98–99.99) (pEC-NRS18) 
to 100% (95% CI 99.9–100) (pEC-393, pEC-125 and pEC-243) plasmid-harbouring cells per generation.
IncX3 plasmids do not contribute to bacterial pathogenicity. Annotation of the four IncX3 plasmids 
revealed the presence of a Type 4 Secretion System (pilX1-11) and several ORFs with unknown function that 
could potentially act as virulence effectors (Fig. 3). The Galleria mellonella in vivo infection model was employed 
to evaluate the impact of harbouring an IncX3 plasmid on bacterial pathogenicity. The LD50 value after 24 h 
was determined to be 107 CFU/larvae and survival curves were compared between the isogenic control E. coli 
DH10b strain and DH10b transformed strains harbouring each of the IncX3 plasmids (Fig. 6). All four trans-
formed strains carrying IncX3 plasmids displayed comparable virulence to the plasmid-free control strain (mor-
tality = 40–86%), with no significant difference in the 96 h survival curves (Fig. 6). In both control groups all 
larvae survived.
Plasmid ID Year Host Host source Resistance gene(s) Size (bp)
GC 
Content %
Open reading 
frames
pEC-NRS18 2009 E. coli ST69/CC69 Human UTI* blaSHV-12, blaTEM-1, qnrS1 48,250 46.4 74
pEC-393 2013 E. coli ST410/CC23 Turkey meat blaSHV-12 43,506 46.8 65
pEC-125 2014 E. coli ST117 Chicken faeces blaSHV-12, qnrS1 46,338 46.4 73
pEC-243 2014 E. coli ST315/CC38 Chicken faeces blaSHV-12, qnrS1 46,338 46.4 73
Table 2. IncX3 plasmids included in this study and their characteristics. *Urinary tract infection.
Figure 2. BioNJ MUMi distances phylogram of IncX3 plasmids. Plasmid sequences obtained here and those 
available in GenBank database were compared pair-wise and maximum unique matches converted to MUMi 
distances were hierarchically clustered and displayed as a phylogram using the BioNJ algorithm. GenBank 
accession number, antibiotic resistant gene content, country and source of isolation are indicated. NL: 
Netherlands, CN: China, CH: Switzerland, IT: Italy, US: United States, BR: Brazil, NG: Nigeria, FR: France, CA: 
Canada, IN: India and AMR: antimicrobial resistance.
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Discussion
Our results confirmed that IncI1α/γ plasmids are the major facilitators of the blaSHV-12 diffusion in E. coli of 
human and animal origin and mirrored the global plasmid repertoire associated with blaSHV-1237,39. However, 
a gradual decrease in the prevalence of IncI1α/γ and a parallel increase in IncX3 plasmids encoding blaSHV-12 
was documented mostly in animal-related commensal E. coli. Previously, the IncX3 plasmid subgroup was only 
incidentally associated with blaSHV-129,16–19 and/or qnrS12,9,12–15 among clinically recovered E. coli isolates, and 
very recently it was identified among poultry isolates in Germany40. IncX3 plasmids have been documented in 
other Enterobacteriaceae worldwide in association with multi-resistance, including to carbapenems18,20,22,24,26,34,36. 
Figure 3. Linear comparison in scale of IncX3 plasmids. The open reading frames identified in each sequence 
are represented with arrows, with the arrowhead indicating the direction of transcription. Their involvement 
in replication, partitioning, transfer, or antibiotic resistance, their association to mobile genetic elements, as 
well as other known or unknown functions and pseudogenes are colour-coded. Areas shaded in grey indicate 
nucleotide identity.
Figure 4. Conjugation frequencies of IncX3 plasmids. The reported values represent the average of three 
independent solid mating experiments (25 °C, 30 °C and 37 °C) and the error bars the standard deviation.
www.nature.com/scientificreports/
8ScIENTIFIc RepoRTS |  (2018) 8:7674  | DOI:10.1038/s41598-018-26073-5
Nevertheless, no association between IncX3 plasmids and other resistance genes (apart from blaSHV-12, blaTEM-1 
and qnrS1) in Enterobacteriaceae was found in the Netherlands (data not shown).
The high degree of synteny and conservation in the backbone of IncX3 plasmids among E. coli isolates of 
both human and animal origin reflects the ecological success of this plasmid subgroup2. In addition to encoding 
genes essential for their maintenance and dissemination, IncX3 plasmids contained a variable region encoding 
resistance to clinically important antimicrobial agents (fluoroquinolones and/or extended spectrum cephalospor-
ins). Our findings confirm the potential of this subgroup for accumulation of resistance genes via IS-mediated 
transposition, with the likely consequence of limiting effective treatment options for possible human infec-
tions9,13,15,16,18,21. As previously described41, the presence of IS26 linked to blaSHV-12 and other co-linear genes 
originating from the chromosome of K. pneumoniae was documented within the IncX3 variable region, confirm-
ing the hypothesis of IS26-mediated mobilization of a blaSHV ancestor gene from the chromosome of K. pneu-
moniae42. Although we cannot prove how blaSHV-12 was integrated into IncX3 plasmids, the documented ability 
of IS26 to participate in both replicative transposition and self-targeted transposition creating IS26-bounded 
transposons43 could have facilitated the formation of the composite blaSHV-12-encoding IS26-IS26 transposon seen 
in the majority of the IncX3 plasmids studied here. The presence of identical composite transposons, mostly on 
plasmids of diverse replicon types, indicates its mobilization ability preferentially onto plasmids rather than the 
chromosome, as previously suggested44. In addition to the contribution of IS26 to the mobilization on conjugative 
plasmids and the subsequent dissemination of blaSHV-12, it has been shown that IS26 supplies a promoter −35 box 
that can be coupled with a −10 box in the adjacent DNA45, possibly also contributing to the expression of this 
resistance gene.
IncX3 plasmids, as well as the archetypal R6K plasmid of the IncX family, have been investigated for their 
ability to conjugate13,15,16,18,19,46. We documented the temperature-dependent transfer of animal-derived IncX3 
plasmids with frequencies higher at 30 °C, suggesting a more efficient transfer in the environment than in the ani-
mal gut. Similarly to other conjugative plasmids, IncX3 plasmids hold a gene encoding a H-NS-like protein2,47–51. 
Several studies demonstrated the inhibitory role of H-NS-like proteins on gene thermoregulation owing to their 
ability to polymerize along and bridge adjacent DNA regions at 37 °C and to derepress H-NS-regulated genes at 
lower temperatures47,48,52. The involvement of these proteins in the temperature-dependent conjugative transfer of 
Figure 5. Relative exponential growth rates of IncX3-harbouring plasmid E. coli DH10b strains. All growth 
rates are set relative to plasmid-free E. coli DH10b. The reported values represent the average of three 
independent experiments and the error bars represent the 95% confidence interval for the ratio.
Figure 6. Impact of harbouring an IncX3 plasmid on E. coli DH10b strain pathogenicity. Kaplan-Meier plot 
of G. mellonella survival after injection with 107 CFU/larva of plasmid-free and IncX3-harbouring plasmid 
(pEC-NRS18, pEC-393, pEC-125 and pEC-243) E. coli DH10b strain is shown. Experiments were performed 
in triplicate and the plot represents the combined (additive) data from all experiments. No larval death was 
observed in control larvae injected with an equivalent volume of PBS.
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IncHI1 plasmids suggests a similar role for IncX3 plasmids that can only be speculated here. The ability of IncX3 
plasmids to replicate and be stably maintained in α-, β- and γ-Proteobacteria53, in combination with a higher con-
jugation frequency at 30 °C, underscore a potential mesophilic Proteobacteria reservoir of this plasmid subgroup.
In contrast with studies describing that plasmids impose fitness cost on their bacterial hosts54, growth kinet-
ics obtained over 24 h showed no evidence of fitness cost on the bacterial E. coli host. It has been demonstrated 
that H-NS-like proteins are able to silence newly introduced foreign sequences (including plasmids), based on 
increased adenine and thymine (AT) content in comparison with the chromosome51,55,56. Taking into consider-
ation the high AT content of the IncX3 plasmids, we hypothesize that the H-NS gene present on these plasmids 
allows them to invade bacterial hosts with a minimal impact on their fitness, ensuring the future competitiveness 
of the new plasmid-host combination even without the presence of antibiotic selective pressure. The significant 
IncX3 plasmid-mediated fitness enhancement of E. coli under antibiotic selective pressure highlights the ecologi-
cal advantage and subsequent successful proliferation of these plasmids in antibiotic-rich reservoirs.
All IncX3 plasmids encoded the widespread partitioning system ParAB ensuring the correct inheritance of 
these plasmids to the daughter cells57. The observed high stability of IncX3 plasmids is potentially due to their 
high conjugation frequency and absence of a fitness burden, as well as to a low rate of segregational loss.
Our data show that IncX3 plasmids encode a type IV secretion system (T4SS, pilX1-11), typically used for the 
exchange of genetic material within bacteria, toxin secretion and the translocation of virulent effector proteins 
into eukaryotic host cells58,59. Yet, a virulence potential of IncX3-carrying E. coli DH10b was not observed, sug-
gesting that T4SS does not play a role in the virulence of E. coli, at least in the G. mellonella model, conversely 
from other Gram-negative pathogens58.
In conclusion, we report the first genetic characterisation of IncX3 plasmids of animal origin, as well as the 
first functional analysis of human- and animal-derived plasmids of this subgroup, including their conjugation 
frequencies, stability, fitness cost and virulence potential. IncX3 plasmids are highly conserved, syntenic, con-
jugative and highly stable, while they exert no fitness cost on their bacterial host, independent of their origin. 
Although clonal expansion of E. coli strains could also play a role as suggested by our finding in The Netherlands 
of E. coli from the same clonal complex and carrying the same IncX3 plasmid (data not shown), the favourable 
plasmid functional features potentially contributed to their emergence amongst SHV-12-producing E. coli in the 
Netherlands, highlighting the epidemic potential of this plasmid subgroup.
Materials and Methods
Bacterial strains, transformants and plasmids. A total of 129 non duplicate blaSHV-12 encoding E. coli, 
consecutively recovered during national antimicrobial resistance monitoring programmes or national projects 
between 2009 and 2014 were included in the study60. Identification of the isolates was performed by MALDI-TOF 
Mass spectrometry (Brucker, Coventry, UK). Genes conferring an ESCR phenotype were sought by microarray 
analysis followed by PCR amplification and sequencing61. Plasmid location of blaSHV-12 was determined using a 
transformation-based approach. Briefly, plasmids encoding blaSHV-12 were extracted from the parental strain using 
a miniprep method and transformed into E. coli DH10b cells (Invitrogen, Van Allen Way, CA USA) by electro-
poration under the following conditions: 1.25 kV/cm, 200 Ω, 25 μFar, as previously described61. Transformants 
were selected on Luria-Bertani (LB) agar plates supplemented with cefotaxime (1 mg/L) and confirmed for the 
presence of blaSHV-12 gene. The presence of a single plasmid in the transformants was confirmed by S1-PFGE 
on the transformants, followed by Southern blot hybridization using DIG-labelled probe (DIG DNA Labeling 
and Detection Kit, Roche, Mannheim, Germany) targeting the blaSHV-12 gene, as previously described62. Plasmid 
typing was confirmed by PCR-based replicon typing (PBRT KIT, DIATHEVA, Fano, Italy) on the transformants. 
Host E. coli sequence type were assigned by MLST based on the allelic profiles of seven housekeeping genes (adk, 
fumC, gyrB, icd, mdh, purA and recA)63.
Plasmid sequencing, assembly and analysis. Four genetically and epidemiologically unrelated IncX3 
plasmids encoding blaSHV-12 were randomly selected for further analysis from E. coli isolates belonging to the 
single ST of human origin (ST69) and diverse STs of animal origin, including the predominant animal-related ST 
(ST117). The relevant characteristics of the selected plasmids are specified in Table 2. Plasmid DNA from trans-
formants was isolated using the QIAfilter Plasmid Midi Kit (QIAGEN, Hilden, Germany) according to the man-
ufacturer’s recommendations. Deep sequencing of the plasmid genomes was performed using 300-bp paired-end 
sequencing libraries (Nextera TAG-mentation sequencing kits [Epicentre]) on an Illumina MiSeq sequencer. 
High-quality filtered reads were subsequently assembled de novo using SPAdes algorithm (SPAdes version 3.7.1) 
for Illumina-derived reads and then manually curated to close the gaps. Putative open reading frames (ORFs) 
were identified by RAST version 2.0 and manually curated when necessary64. BLASTP analyses of the putative 
ORFs against the NCBI non-redundant proteins (NR) database, Pfam, and Interpro scan were used to assess their 
putative functions by identification of structural features and motifs65,66. ResFinder (version 2.1), PlasmidFinder 
(version 1.3) and ISfinder were used to determine the presence of resistance genes, replicon types and insertion 
sequences, respectively67–69. Plasmid sequences were hierarchically clustered and displayed as a phenogram using 
the BioNJ algorithm, where the underlying distance matrix was calculated from the pairwise non-overlapping 
maximal unique matches (MUMs) using Nucmer version 3.0770,71. Relative pairwise distances were obtained 
by dividing the pairwise MUMs’ sum by the average genome size of the two paired genomes (MUMi genomic 
distance)72. BioNJ trees were generated from the MUMi distance matrix using SplitsTree473. BLAST analysis was 
used to assess sequence identity between the blaSHV-12-surrounding region and nucleotide sequences deposited 
to NCBI74.
Mating assays. Plasmid conjugation was assessed in solid mating assays at 25 °C, 30 °C and 37 °C conducted 
in triplicate. Chloramphenicol resistant (chlorR) E. coli MG1655::yfp was used as a recipient strain in 1:1 ratio 
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with donor E. coli DH10b transformed strains carrying the different IncX3 plasmids, as previously described75. 
Overnight cultures of recipient and donor strains in mid-exponential phase were co-incubated (100 μl each) onto 
sterile nitrocellulose filters of 0.45 μm pore size (Schleicher and Schuell GmbH, Dassel, Germany) for 4 h at 25 °C, 
30 °C and 37 °C. Transconjugants were selected on LB agar supplemented with chloramphenicol (32 mg/L) and 
cefotaxime (1 mg/L). Positive transconjugants were confirmed by PCR amplification for the resistance and yfp 
genes. Conjugation frequency was calculated as the number of transconjugants per donor cell, with the absence 
of transconjugants suggesting either non-conjugative plasmids or conjugation frequencies below the detection 
limit (≤1 × 10−9). For statistical analysis, conjugation frequencies were transformed to log10 values, the differ-
ences between the temperatures and plasmids were tested using a non-parametric Kruskal-Wallis test, and a p 
value < 0.05 was considered to be statistically significant. All analysis was performed using R and RStudio (ver-
sion 1.0.143)76,77.
Fitness cost assays. Liquid cultures of E. coli DH10b transformed strains carrying different IncX3 plasmids 
were incubated overnight in 3 mL LB medium at 37 °C with 180 rpm shaking. Cultures were then diluted 100-fold 
into 3 mL of fresh pre-warmed LB medium with and without antibiotic (1 mg/L of cefotaxime) and incubated 
under the same conditions until mid-exponential phase (OD600 of ≈0.5). 200 µL of each culture were loaded in 
triplicate in wells of a 100-well honeycomb plate and incubated at 37 °C with shaking for 24 h. Growth rates were 
obtained by measuring optical density at 600 nm every 30 min by using a Bioscreen C Reader (Oy Growth Curves, 
Helsinki, Finland). Assays were performed in triplicate. Relative growth rates were calculated by dividing the gen-
eration time of each DH10b transformed strain by the generation time of the wild-type DH10b strain which was 
included in each individual assay78. Growth rates between strains were compared using the Wilcoxon rank sum 
test with a Bonferroni adjustment for multiple comparisons. All statistical analysis were performed in R studio 
(version 1.0.143)76.
Stability assays. E. coli DH10b transformants carrying different IncX3 plasmids were propagated in 
antibiotic-free LB medium at 37 °C with 180 rpm shaking for 10 days (∼180 generations) to determine their sta-
bility in an E. coli population. Cultures of each strain were daily diluted 1000-fold into 3 mL of fresh pre-warmed 
LB medium without antibiotics. On day 10, cultures were plated onto antibiotic-free LB agar and 100 randomly 
chosen colonies of each evolved line were replica-plated onto antibiotic-free and antibiotic-containing (1 mg/L of 
cefotaxime) LB agar plates. Plasmid presence was confirmed by colony PCR targeting the taxC gene of the IncX3 
plasmids2. Colony growth on antibiotic-free but not on antibiotic-containing plates indicated the proportion 
of bacteria that lost the plasmid. Assays were performed in triplicate. The chance of E. coli DH10b keeping the 
plasmid was estimated for every plasmid using @Risk 6.3.1 (Palisade Corporation, Newfield, NY, USA), and the 
proportions of plasmid-harbouring colonies for each plasmid were compared.
Galleria mellonella survival assays. G. mellonella caterpillars in the final-instar larval stage were obtained 
in bulk from Livefood UK Limited (Rooks Bridge, Somerset, United Kingdom) and stored at 15 °C in the dark on 
wood shavings prior to use. Ten randomly chosen larvae weighing between 250 mg and 350 mg were employed 
for each group of an experiment. Strains included in the assay were grown overnight in LB broth and washed 
twice in sterile phosphate-buffered saline (PBS). The optimal bacterial inoculum was determined by injecting 10 
larvae with 10 μl of bacterial suspensions containing 104 to 107 CFU/larva of organism in PBS. Bacterial inocu-
lum concentration was determined by viable bacterial count on LB agar identifying the inoculum which killed 
50% of larvae after 24 hours incubation at 37 °C (LD50). The optimal inoculum was then injected into the hemo-
coels of the caterpillars via a left proleg using 25-μl Hamilton syringes (Cole-Parmer, London, United Kingdom). 
Following injection, larvae were incubated in petri dishes lined with filter paper at 37 °C for 96 h and scored for 
survival by 2 independent observers daily. Larvae were considered dead when they displayed no movement in 
response to touch. Two control groups were used per experiment, including larvae that were inoculated with PBS 
to control for any lethal effects of the injection process and larvae that received no injection. All G. mellonella 
survival assays were performed in triplicate using different batches of larvae. Survival curves were plotted using 
the Kaplan-Meier method and differences in survival were calculated by the log-rank test using R studio (version 
1.0.143)76.
Data availability. All data generated or analysed during this study are included in this published article (and 
its Supplementary Information files).
Accession codes. The reported plasmid sequences are deposited in GenBank under the following accession 
numbers: KX618696 (pEC-NRS18), KX618697 (pEC-393), KX618698 (pEC-243) and KX618703 (pEC-125).
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